Non-injection Drug Abuse and HIV/AIDS


The purpose of this program announcement with set-aside funds from the National Institute on Drug Abuse is to encourage drug abuse research that elucidates the contribution of non-injection drug abuse to the acquisition and/or transmission and/or disease progression of HIV/AIDS. Specifically, it seeks to: 1) investigate how, where, why, and among whom HIV/AIDS is spreading through non-injection drug use associated high-risk sexual behavior; 2) develop effective prevention and treatment interventions for non-injection drug users at risk for or infected with HIV; and 3) improve accessibility and utilization of evidence-based, integrated care for non-injection drug abuse, risky sexual behavior, and HIV/AIDS and other infectious diseases. While both the National Institute on Drug Abuse (NIDA) and the National Institute on Mental Health (NIMH) are participating in this Program Announcement, only NIDA has set aside funds specifically for this program.

The link to the full announcement is grants.nih.gov/grants/guide/pa-files/PAS-06-054.html

Eligible applicants include:
State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility:
Eligible agencies of the Federal government are eligible to apply
Foreign Institutions are eligible to apply

Leave a Reply

You must be logged in to post a comment.